Tina S. Wu

Sexual Dysfunction Secondary to Gemfibrozil

C. James, Tina S. Wu, K. McNelis, 2002, Pharmacotherapy.

Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study

P. Wang, Ya‐Wen Cheng, Y. Tyan, 2010, Archives of Gynecology and Obstetrics.

Adding the p16INK4a Marker to the Traditional 3-marker (ER/Vim/CEA) Panel Engenders No Supplemental Benefit in Distinguishing Between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Study

Ya‐Wen Cheng, Y. Tyan, Ming-Yung Lee, 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Scoring of p16INK4a immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

P. Wang, Ya‐Wen Cheng, Shun-Fa Yang, 2009, Modern Pathology.

Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension stu

K. Chao, P. Wang, Y. Tyan, 2009, Journal of Translational Medicine.

Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study

K. Chao, Ya‐Wen Cheng, Ming-Yung Lee, 2009, Journal of Translational Medicine.

Ancillary p16INK4a adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study

P. Wang, Ya‐Wen Cheng, Y. Tyan, 2009, Archives of Gynecology and Obstetrics.

Five commonly used markers (p53, TTF1, CK7, CK20, and CK34βE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study

P. Wang, Ya‐Wen Cheng, Y. Tyan, 2010, Archives of Gynecology and Obstetrics.